NeoLumina Partners with Catalent to Pioneer Psilocin Delivery, Marking a Major Leap in Psychedelic Med for Mental Health
NeoLumina is a life sciences company that aims to develop effective first-line therapeutics based on psychedelics for mental health disorders such as eating disorders, depression, anxiety, pain, and addictions. Pioneering Precision: NeoLumina and Catalent Partner to Redefine Psilocin Delivery for Mental Health Treatment. VANCOUVER, BRITISH COLUMBIA, CANADA, November 7, 2025 /EINPresswire.com/ — NeoLumina BioScience Inc., … Read more